Oral Limonene: Combined Prenylation Inhibitor Therapy of Cancer
- 1 January 1998
- journal article
- Published by Mary Ann Liebert Inc in Journal of Medicinal Food
- Vol. 1 (2) , 83-88
- https://doi.org/10.1089/jmf.1998.1.83
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of actionAnti-Cancer Drugs, 1996
- LimoneneJournal of Applied Toxicology, 1995
- Effectiveness of combined limonene and 4-hydroxyandrostenedione in the treatment of NMU-induced rat mammary tumoursBritish Journal of Cancer, 1994
- Limonene trial in cancerThe Lancet, 1993
- FUNCTION AND REGULATION OF RASAnnual Review of Biochemistry, 1993
- Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oilsCarcinogenesis: Integrative Cancer Research, 1991
- Genetic and Pharmacological Suppression of Oncogenic Mutations in RAS Genes of Yeast and HumansScience, 1989
- Inhibition of Murine Subcutaneous and Intravenous Benzo(rst)pentaphene Carcinogenesis by Sweet Orange Oils and d-LimoneneOncology, 1971